ONVO
- Organovo Holdings, Inc.
()
Overview
Company Summary
Organovo Holdings, Inc. is a biotechnology company that specializes in the creation of three-dimensional (3D) human tissues for medical research and therapeutic applications. The company's innovative technology, known as 3D bioprinting, allows them to manufacture functional human tissue constructs using a layer-by-layer printing process.
By combining bioink, which are live human cells, and a support gel, Organovo's bioprinting technology can replicate the complexity and architecture of human tissues. These tissues can be used for a variety of purposes such as drug discovery, preclinical testing, and even addressing the shortage of donor organs for transplantation in the future.
Organovo primarily focuses on developing and commercializing its 3D bioprinted liver tissues, which are utilized by pharmaceutical companies to evaluate the efficacy and toxicity of new drug candidates more accurately. These liver tissues contain functional cell types, including hepatocytes, which perform essential liver functions and respond to drugs similarly to the human liver.
In addition to liver tissues, Organovo is also working on developing other human tissues, including kidney and lung, to expand its portfolio and address the needs of various therapeutic and research applications. This technology has the potential to revolutionize the pharmaceutical industry by providing more accurate and reliable in vitro testing models, reducing the cost and failure rate of drug development.
Organovo operates as a commercial provider of these 3D bioprinted human tissues and also collaborates with pharmaceutical and academic partners to further advance the applications of its technology. Through strategic partnerships, they aim to create solutions that can improve drug development, personalized medicine, and ultimately enhance patient outcomes.
Overall, Organovo Holdings, Inc. is at the forefront of 3D bioprinting technology, utilizing its capabilities to engineer human tissues for a range of medical and research purposes with the goal of transforming the field of biomedicine.